DIANOVATOR AB is a start-up in diabetes technology. We develop a patient-specific decision support system for improved glycemic control by optimized insulin dosing. Our target audience is patients receiving insulin therapy using insulin pens or insulin pumps. Many of these patients experience difficulties optimizing their therapy, resulting in reduced life quality and a shorter life expectancy. Our product can help them achieve a better control, thereby reducing anxiety and lowering the risk of short and long term complications associated with poor glycemic control. Our system relies on established proven sensor technology already available on the market.

Copyright © All Rights Reserved